---
title: "Panacea Biotec Ltd (PANACEABIO) — Share Price, Financials & Analysis"
symbol: "PANACEABIO"
company: "Panacea Biotec Ltd"
canonical: "https://tapetide.com/stocks/PANACEABIO"
isin: "INE922B01023"
nse_symbol: "PANACEABIO"
bse_code: "531349"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 2364.59
generated_at: "2026-09-13T19:07:45.823Z"
---

# Panacea Biotec Ltd (PANACEABIO)

Canonical page: https://tapetide.com/stocks/PANACEABIO

## Company

- **NSE Symbol:** PANACEABIO
- **BSE Code:** 531349
- **ISIN:** INE922B01023
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 1996-04-17
- **CEO:** Dr. Rajesh Jain Ph.D.
- **Employees:** 2149
- **Face Value:** ₹1
- **F&O Eligible:** No
- **Website:** panaceabiotec.com

## About

Incorporated in 1984, Panacea Biotec Ltd is a research-based biotechnology company[1]

## Latest Price

- **Price:** ₹397.65
- **Change:** +9 (+2.32%)
- **Open:** ₹387.9
- **Day High:** ₹399.95
- **Day Low:** ₹383.45
- **Previous Close:** ₹388.65
- **Volume:** 89281
- **As Of:** 2026-09-11T09:59:47+00:00

## Key Fundamentals

Observed at 2026-09-11T04:38:47.629559Z.

- **Market Cap:** ₹2364.59 Cr
- **Classification:** Microcap
- **P/E (reported):** -266
- **EPS (TTM):** ₹-1.16
- **Book Value:** ₹136.3
- **Price to Book:** 2.85
- **Dividend Yield:** 0%
- **ROE:** -1.05%
- **ROCE:** -0.44%
- **Debt to Equity:** 0.03
- **Revenue (yearly):** ₹639.77 Cr
- **Net Income:** ₹-7.8 Cr
- **EBITDA:** ₹-4.66 Cr
- **52-Week High:** ₹647
- **52-Week Low:** ₹292.4
- **RSI (14):** 40.64

## Tapetide Score

- **Score:** 47 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Falling
- **Percentile:** 35.6 (of 4473 scored stocks)
- **Confidence:** 91%
- **Data coverage:** 81%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 43.12 | 9% |
| growth | 35.94 | 9% |
| momentum | 42.25 | 12% |
| ownership | 78.59 | 24% |
| quality | 34.35 | 22% |
| valuation | 31.63 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.

### Weaknesses

- Stock is trading at 2.92 times its book value
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 0.47% over past five years.
- Company has a low return on equity of -3.48% over last 3 years.
- Earnings include an other income of Rs.26.4 Cr.
- Company's cost of borrowing seems high

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | — | 93.52% | -125.64% |
| ebitda margin growth | 62.82% | -24.18% | -170.41% | 109.09% |
| net income growth | 320% | -10.34% | 21% | 13% |
| revenue growth | 20.12% | 10.34% | 12% | 0% |
| roce | — | -181.48% | -124.04% | 34.7% |
| roe | -320% | 483.33% | -1.75% | -101.66% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 143.02 | 150.5 | 136.46 | 115.72 | 147.35 | 163.49 | 132.53 | 166.7 | 141.13 | 165.19 | 166.75 | 199.57 |
| Expenses | 146.58 | 150.65 | 142.5 | 129.71 | 140.35 | 155.53 | 159.41 | 167.88 | 158.92 | 153.45 | 164.18 | 193.9 |
| Operating Profit | -3.56 | -0.15 | -6.04 | -13.99 | 7 | 7.96 | -26.88 | -1.18 | -17.79 | 11.74 | 2.57 | 5.67 |
| OPM % | -2.49 | -0.1 | -4.43 | -12.09 | 4.75 | 4.87 | -20.28 | -0.71 | -12.61 | 7.11 | 1.54 | 2.84 |
| Other Income | 6 | 8.46 | 13.55 | 6.54 | 7.42 | 6.39 | 36.3 | 16.99 | 9.1 | 5.05 | 5.26 | 6.98 |
| Interest | 0.91 | 0.85 | 0.82 | 0.87 | 0.98 | 0.99 | 1.04 | 0.86 | 2.14 | 1.85 | 1.2 | 1.18 |
| Depreciation | 9.31 | 9.11 | 8.81 | 8.73 | 8.68 | 8.98 | 8.42 | 8.39 | 8.34 | 8.45 | 7.88 | 7.9 |
| Profit before tax | -7.78 | -1.65 | -2.12 | -17.05 | 4.76 | 4.38 | -0.04 | 6.56 | -19.17 | 6.49 | -1.25 | 3.57 |
| Tax % | 6.56 | 33.33 | -6.13 | -6.86 | 1.05 | -1.37 | 4875 | 39.63 | -26.92 | 40.06 | -20 | 38.38 |
| Net Profit | -8.29 | -2.2 | -1.99 | -15.88 | 4.71 | 4.44 | -1.99 | 3.96 | -14.01 | 3.89 | -1 | 2.2 |
| EPS in Rs | -1.35 | -0.37 | -0.32 | -2.58 | 0.78 | 0.74 | -0.31 | 0.66 | -2.27 | 0.65 | 0.08 | 0.38 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 593 | 457 | 544 | 625 | 661 | 460 | 559 | 559 | 640 | 673 |
| Expenses | 509 | 591 | 484 | 548 | 674 | 558 | 579 | 584 | 644 | 670 |
| Operating Profit | 84 | -134 | 60 | 77 | -13 | -98 | -20 | -25 | -5 | 2 |
| OPM % | 14 | -29 | 11 | 12 | -2 | -21 | -3.5 | -4.4 | -0.7 | 0.3 |
| Other Income | 8 | 338 | -21 | 9 | 1687 | 154 | 62 | 55 | 36 | 26 |
| Interest | 101 | 105 | 174 | 185 | 181 | 4 | 4 | 4 | 6 | 6 |
| Depreciation | 57 | 54 | 43 | 46 | 44 | 39 | 37 | 35 | 33 | 33 |
| Profit before tax | -66 | 45 | -178 | -146 | 1449 | 13 | 1 | -8 | -7 | -10 |
| Tax % | 15 | 17 | 9 | 1 | 26 | 363 | 201 | 10 | -3 | — |
| Net Profit | -76 | 38 | -194 | -148 | 1078 | -34 | -2 | -9 | -7 | -9 |
| EPS in Rs | -12.07 | 6.15 | -31.69 | -24.09 | 175.91 | -5.42 | -0.19 | -1.37 | -0.88 | -1.16 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 350 | 303 | 344 | 193 | -235 | 871 | 837 | 836 | 829 | 829 |
| Borrowings | 994 | 941 | 646 | 742 | 820 | 34 | 20 | 21 | 22 | 24 |
| Other Liabilities | 440 | 349 | 379 | 449 | 587 | 848 | 407 | 378 | 433 | 404 |
| Total Liabilities | 1789 | 1598 | 1376 | 1390 | 1178 | 1759 | 1271 | 1241 | 1290 | 1262 |
| Fixed Assets | 1001 | 949 | 806 | 657 | 609 | 622 | 600 | 582 | 567 | 620 |
| CWIP | 30 | 40 | 23 | 24 | 34 | 17 | 42 | 102 | 128 | 100 |
| Investments | 7 | 7 | 5 | 6 | 0 | 5 | 13 | 40 | 3 | 10 |
| Other Assets | 750 | 602 | 542 | 703 | 534 | 1114 | 615 | 517 | 592 | 532 |
| Total Assets | 1789 | 1598 | 1376 | 1390 | 1178 | 1759 | 1271 | 1241 | 1290 | 1262 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 131 | 118 | 105 | -30 | 107 | -108 | -422 | 0 | -27 | 17 |
| Cash from Investing Activity | -26 | 55 | -6 | -35 | -48 | 1283 | 430 | 10 | 65 | -40 |
| Cash from Financing Activity | -107 | -164 | -101 | 91 | -47 | -1176 | -18 | -3 | -3 | -1 |
| Net Cash Flow | -2 | 9 | -2 | 26 | 12 | -2 | -10 | 7 | 35 | -25 |
| Free Cash Flow | 107 | 103 | 100 | -21 | 89 | -119 | -424 | -71 | -77 | -37 |
| CFO/OP | 320 | 146 | -77 | -36 | 141 | -2235 | 429 | -12 | 108 | -496 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 95 | 84 | 71 | 46 | 49 | 45 | 48 | 37 | 47 | 42 |
| Inventory Days | 770 | 651 | 173 | 344 | 311 | 296 | 292 | 282 | 391 | 251 |
| Days Payable | 607 | 540 | 572 | 463 | 440 | 327 | 256 | 244 | 413 | 247 |
| Cash Conversion Cycle | 259 | 195 | -328 | -73 | -80 | 14 | 83 | 76 | 25 | 46 |
| Working Capital Days | -46 | -96 | -363 | 93 | -43 | -229 | -5 | -2 | 44 | 57 |
| ROCE % | 2 | 3 | -16 | 5 | 5 | -6 | -10 | -4 | -5 | -2 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 73.59% | 73.59% | 73.59% | 73.46% | 72.87% | 72.49% | 72.48% | 72.48% | 72.48% | 72.48% | 72.48% | 72.48% |
| FIIs | 0% | 0% | 0.27% | 0.27% | 0.37% | 0.38% | 1.16% | 0.78% | 1.06% | 1.36% | 1.6% | 2.31% |
| DIIs | 0% | 0% | 0.84% | 1.07% | 1.16% | 1.17% | 1.49% | 1.52% | 1.81% | 1.85% | 1.97% | 2.25% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 19.2% | 19.63% | 19.9% | 20.42% | 18.11% | 18.98% | 18.45% | 18.17% | 17.69% | 17.49% | 16.81% | 15.54% |
| Others | 7.21% | 6.78% | 5.4% | 4.79% | 7.49% | 6.99% | 6.41% | 7.05% | 6.96% | 6.81% | 7.15% | 7.42% |
| No. of Shareholders | 48878 | 47091 | 46242 | 45513 | 39982 | 35446 | 33593 | 34256 | 33593 | 34597 | 32620 | 33532 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 4 / 6 / 9

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 388.1 | Buy |
| EMA (10) | 391.6 | Buy |
| SMA (20) | 396.31 | Buy |
| EMA (20) | 398.26 | Sell |
| SMA (50) | 439.37 | Sell |
| EMA (50) | 422.91 | Sell |
| SMA (100) | 448.61 | Sell |
| EMA (100) | 428.39 | Sell |
| SMA (200) | 400.88 | Sell |
| EMA (200) | 421.19 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 45.95 | Neutral |
| MACD (12,26,9) | -11.82 | Buy |
| Stochastic (14,3,3) | 53.08 | Neutral |
| ADX (14) | 13.89 | Neutral |
| Williams %R (14) | -31 | Neutral |
| ATR (14) | 16.29 | High Volatility |
| ROC (12) | -0.08 | Sell |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 44.7 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-08 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0eba84c3-8ec8-415d-8989-8142c034ed68.pdf) |
| 2026-09-07 | [Details Of Shares Dematerialized During August 2026 Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d01d7e7-69c4-4dff-9a21-94981ce85db9.pdf) |
| 2026-09-07 | [Notice Of Annual General Meeting To Be Held On September 29 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=007e0368-6aac-40c8-b7f6-4b9eacb7626b.pdf) |
| 2026-09-07 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b5b10892-af95-4864-a35a-cb3af050cb60.pdf) |
| 2026-09-07 | [Business Responsibility and Sustainability Reporting (BRSR)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dc725aed-f028-4fa9-8e5f-0cae32e7dbeb.pdf) |
| 2026-09-07 | [Confirmation On Letter Being Sent To The Concerned Shareholders Providing The Weblink For Accessing The Annual Report For Financial Year 2025-26 And The Notice Of The Ensuing AGM To Be Held On September 29 2026 Through Video Conferencing / Other Audio-Vis](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f143c0d-5262-4c91-a31b-8c61382f0321.pdf) |
| 2026-09-07 | [Book Closure For Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08c3c5ca-bf90-429c-86b8-c79629c8b5bb.pdf) |
| 2026-08-18 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11a22e63-7edf-49aa-8ac3-7428002c1b43.pdf) |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3663369a-3943-4fb3-bf74-0df9f701579c.pdf) |
| 2026-08-13 | [Board Meeting Outcome for Outcome Of Board Meeting Held On August 13 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a8b7189-3373-4637-ad95-8dfa6db5867d.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-13 | [Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=feb51b59-cd12-4fec-bd36-7bf53b39452c.pdf) |
| 2026-05-31 | [Audited Financial Results For Quarter And Financial Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dd2d835d-f3b2-441a-a5f1-e6805ab0f5ab.pdf) |
| 2026-02-11 | [Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Nine Months Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ca9ac6e-5776-4f30-81c2-d3ab97427844.pdf) |
| 2025-11-14 | [Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Half Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=168e22ef-d456-40bd-99ff-dc4ce5d7ddcc.pdf) |
| 2025-08-14 | [Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter Ended 30.06.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae14fd81-cc46-4e60-903b-65a3c8bd21f2.pdf) |
| 2025-05-30 | [Standalone And Consolidated Audited Financial Results Along With Auditors Report For The Quarter And Financial Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c9c2b03f-7688-4c0e-8880-188d6b327f8c.pdf) |
| 2025-02-14 | [Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Nine Months Ended December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c6930f3c-9142-4881-8bfb-97a1ef113ac7.pdf) |
| 2024-11-13 | [Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Half Year Ended September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=673fc0ef-0ffd-4bb8-94c3-10df0ee870e3.pdf) |
| 2024-08-14 | [Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter Ended 30.06.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=103231a5-6a34-4ed3-9ba5-aa26766593e5.pdf) |
| 2024-05-30 | [Standalone And Consolidated Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64585325-909c-468f-b4f3-8f447ed63d93.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9h - Demand Order dated 30‑Mar‑2026: GST ~₹11.44 Cr plus ~₹11.44 Cr penalty (total ~₹22.88 Cr) for Apr 2019–Mar 2022. | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 9h - Demand Order dated 30‑Mar‑2026: GST ~₹11.44 Cr plus ~₹11.44 Cr penalty (total ~₹22.88 Cr) for Apr 2019–Mar 2022.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/f85d73f8-1169-4f3a-a788-b7763f078604.pdf) |
| 7 May - No shares dematerialized in April 2026; total demat shares remained 6,11,04,526. | [Details Of Shares Dematerialized During April 2026 Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations, 2018 7 May - No shares dematerialized in April 2026; total demat shares remained 6,11,04,526.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/2ca4f620-a4b1-4ca7-b7f2-62827f242a81.pdf) |
| 7 Apr - No share has been dematerialised during the month of March 2026. A copy of the certificate obtained from the Company''s RTA viz. Skyline Financial Services … | [Demat Status Report For The Month Of March, 2026 7 Apr - No share has been dematerialised during the month of March 2026. A copy of the certificate obtained from the Company''s RTA viz. Skyline Financial Services …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fba11c8e-5fb3-4ee6-a46b-44e6d1123a95.pdf) |
| 7 Apr - DCIT rectified April 6, 2026 assessment order; AY2016-17 tax liability reduced from ₹10.23 crore to nil. | [Receipt Of Rectified Assessment Order For AY 2016-17 7 Apr - DCIT rectified April 6, 2026 assessment order; AY2016-17 tax liability reduced from ₹10.23 crore to nil.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/85d34433-095e-4560-935c-d9979725a42b.pdf) |
| 7 Apr - Compliance certificate under Regulation 74(5) for quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Apr - Compliance certificate under Regulation 74(5) for quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b431faf9-9b43-4cb7-bd32-5a340b94a90a.pdf) |
| 6 Mar - Reports 3,000 shares dematerialized in February 2026; total 61,104,526 shares as of Feb 28, 2026. | [Demat Status Report For The Month Of February 2026 6 Mar - Reports 3,000 shares dematerialized in February 2026; total 61,104,526 shares as of Feb 28, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7b6cecb3-90a7-439b-8d9e-75ce599cbc5c.pdf) |
| 6 Mar - Received Demand Order (01-Mar-2026) for ~₹10.23 Crore tax demand relating to AY2016-17; company to appeal. | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 6 Mar - Received Demand Order (01-Mar-2026) for ~₹10.23 Crore tax demand relating to AY2016-17; company to appeal.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b8378430-cfee-4644-9390-e4e0d4b14fe1.pdf) |
| 30 Mar - CA Rajesh Jain resigns as Independent Director of Panacea Biotec and PBPL, effective close of business June 30, 2026. | [Announcement under Regulation 30 (LODR)-Resignation of Director 30 Mar - CA Rajesh Jain resigns as Independent Director of Panacea Biotec and PBPL, effective close of business June 30, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7d8027a3-477e-4bd1-98f3-86192cbfcc25.pdf) |
| 30 Apr - ITAT allowed Panacea Biotec’s appeal, cancelling ₹9.16 crore demand for AY2020-21. | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 30 Apr - ITAT allowed Panacea Biotec’s appeal, cancelling ₹9.16 crore demand for AY2020-21.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/69e82461-b743-47d1-b487-922d12d352ff.pdf) |
| 30 Apr - ITAT allowed Panacea Biotec’s appeal, cancelling ₹9.16 crore demand for AY2020-21. | [Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 30 Apr - ITAT allowed Panacea Biotec’s appeal, cancelling ₹9.16 crore demand for AY2020-21.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/69e82461-b743-47d1-b487-922d12d352ff.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2013 from nse](https://archives.nseindia.com/annual_reports/AR_1362_PANACEABIO_2012_2013_05092013153412.zip) |
| from nse | [Annual Report 2012 from nse](https://archives.nseindia.com/annual_reports/AR_PANACEABIO_2011_2012_25092012120202.zip) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ff14212f-1b94-4900-a856-ce6759b4e6ab.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f21bfdd7-0e3d-4845-b509-69f8a7e3bbbc.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e13a2b1f-d90e-423e-9fef-e4da915d65c7.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/531349/76494531349.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/531349/71281531349.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/531349/67788531349.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/531349/5313490319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/531349/5313490318.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2021-08-02 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2cee182a-92e6-42da-8a95-a26a9fd929bf.pdf) |
| 2021-07-28 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec4d923a-0b87-44b8-b2af-7f0341872c97.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Jul 2021 | [Concall - Jul 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ec4d923a-0b87-44b8-b2af-7f0341872c97.pdf) |
| Aug 2021 | [Concall - Aug 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2cee182a-92e6-42da-8a95-a26a9fd929bf.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:07:45.823Z.